Atazanavir
Sold as Aspen atazanavir, Atazor, Avirtaz, Atahiv, Viratan, Zorovir, Anovavir, Atazanavir cipla, Synthitaz, Reyataz
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 8
- Registrations
- 26
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pharmacare limited û woodmead | Aspen atazanavir | 150 mg, 200 mg | 420838, 420839 | Not determined | None |
| Emcure- Pharmaceutical South Africa (Pty) LtdCancelled | Atazor, Atahiv | 100, 150, 200, 300 | 430234, 430235, 430236, 460682, 480979, 480980, 480981, 480982 | Not determined | None |
| Viatris Healthcare (Pty) LtdCancelled | Avirtaz | 150 mg, 300 mg | 460970, 460971 | Not determined | None |
| Aurogen South Africa (Pty) Ltd | Viratan | 150 mg, 200 mg, 300 mg | 490191, 490192, 490193 | Not determined | None |
| Aurobindo Pharma (Pty) Ltd | Zorovir | 150 mg, 200 mg, 300 mg | 490194, 490195, 490196 | Not determined | None |
| Novagen Pharma (Pty) Ltd1 of 2 cancelled | Anovavir | 150, 200 | 490705, 490706 | Not determined | None |
| Cipla Medpro (Pty) LtdCancelled | Atazanavir cipla, Synthitaz | 150, 200 | 510238, 510239, 510240.238, 510241.239 | S4 | None |
| Equity Pharmaceutical (Pty) LtdCancelled | Reyataz | 150 mg, 200 mg | A390088, A390089 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Aspen atazanavir 150 MG EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 150,0 mg | 150 mg | 42083842/20.2.8/0838 | Registered | Not determined | None |
| Aspen atazanavir 200 MG EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 200,0 mg | 200 mg | 42083942/20.2.8/0839 | Registered | Not determined | None |
| Atazor-100 EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 100,0 mg | 100 | 43023443/20.2.8/0234 | Cancelled | Not determined | None |
| Atazor-150 EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 150,0 mg | 150 | 43023543/20.2.8/0235 | Cancelled | Not determined | None |
| Atazor-200 EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 200,0 mg | 200 | 43023643/20.2.8/0236 | Cancelled | Not determined | None |
| Atazor 300 EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 300,0 mg | 300 | 46068246/20.2.8/0682 | Cancelled | Not determined | None |
| Avirtaz 150 MG EACH CAPSULE CONTAINS ATAZANAVIR 150,0 mg | 150 mg | 46097046/20.2.8/0970 | Cancelled | Not determined | None |
| Avirtaz 300 MG EACH CAPSULE CONTAINS ATAZANAVIR 300,0 mg | 300 mg | 46097146/20.2.8/0971 | Cancelled | Not determined | None |
| Atahiv 100 EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 100,0 mg | 100 | 48097948/20.2.8/0979 | Cancelled | Not determined | None |
| Atahiv 150 EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 150,0 mg | 150 | 48098048/20.2.8/0980 | Cancelled | Not determined | None |
| Atahiv 200 EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 200,0 mg | 200 | 48098148/20.2.8/0981 | Cancelled | Not determined | None |
| Atahiv 300 EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 300,0 mg | 300 | 48098248/20.2.8/0982 | Cancelled | Not determined | None |
| Viratan 150 MG EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 150,0 mg | 150 mg | 49019149/20.2.8/0191 | Registered | Not determined | None |
| Viratan 200 MG EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 200,0 mg | 200 mg | 49019249/20.2.8/0192 | Registered | Not determined | None |
| Viratan 300 MG EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 300,0 mg | 300 mg | 49019349/20.2.8/0193 | Registered | Not determined | None |
| Zorovir 150 MG EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 150,0 mg | 150 mg | 49019449/20.2.8/0194 | Registered | Not determined | None |
| Zorovir 200 MG EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 200,0 mg | 200 mg | 49019549/20.2.8/0195 | Registered | Not determined | None |
| Zorovir 300 MG EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 300,0 mg | 300 mg | 49019649/20.2.8/0196 | Registered | Not determined | None |
| Anovavir 150 EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 150,0 mg | 150 | 49070549/20.2.8/0705 | Cancelled | Not determined | None |
| Anovavir 200 EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 200,0 mg | 200 | 49070649/20.2.8/0706 | Registered | Not determined | None |
| Atazanavir cipla 150 capsules EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE 150,0 mg | 150Capsules | 51023851/20.2.8/0238 | Cancelled | S4 | None |
| Atazanavir cipla 200 capsules EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE 200,0 mg | 200Capsules | 51023951/20.2.8/0239 | Cancelled | S4 | None |
| Synthitaz 150 EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE 150,0 mg | 150 | 510240.23851/20.2.8/0240.238 | Cancelled | S4 | None |
| Synthitaz 200 EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE 200,0 mg | 200 | 510241.23951/20.2.8/0241.239 | Cancelled | S4 | None |
| Reyataz 150 MG EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 150,0 mg | 150 mg | A390088A39/20.2.8/0088 | Cancelled | Not determined | None |
| Reyataz 200 MG EACH CAPSULE CONTAINS ATAZANAVIR SULPHATE EQUIVALENT TO ATAZANAVIR 200,0 mg | 200 mg | A390089A39/20.2.8/0089 | Cancelled | Not determined | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Atazanavir sulphate
S4: Atazanavir
Consolidated Schedules 06 July 2026, line 5370
Pharmacological class: Antiviral agents. (class 20.2.8)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.